A human monoclonal antibody type IgG4, designated 1Ff4, was obtained by Epstein Barr virus transformation of peripheral blood lymphocytes from a hepatitis B vaccinee (HB-VAX: plasmaderived vaccine) after one boost of yeast recombinant DNA derived vaccine (Engerix-B). 1Ff4 binds preferentially to HBs
Distribution of IgG subclasses after anti-hepatitis B virus immunization with a recombinant vaccine
✍ Scribed by M. C. Honorati; R. M. Borzì; P. Dolzani; S. Toneguzzi; A. Facchini
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 396 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0940-5437
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background In the present study, we evaluated the safety of CIGB‐230, a novel vaccine candidate based on the mixture of a plasmid for DNA immunization, expressing hepatitis C virus (HCV) structural antigens, with a recombinant HCV Core protein. ## Methods Fifteen HCV chronically‐i
Genotypes B and C are the major hepatitis B virus (HBV) genotypes in Taiwan, and genotype C is associated with more severe liver disease than genotype B. Whether the implementation of the hepatitis B immunization program has affected the secular trend of the HBV genotype distribution remains unknown
The cytotoxic T lymphocyte (CTL) response of infants after immunization with either inactivated trivalent subvirion vaccine (TIV) or bivalent attenuated cold-recombinant (CR) vaccine or occurrence of natural influenza virus infection were compared in a blinded, placebo-controlled study during the 19
## Abstract A prospective study of the immune response after hepatitis B vaccination was carried out in 32 insulin dependent diabetes mellitus (IDDM) patients and their age and sex matched healthy controls. A sensitive, immunoenzymatic technique was used, able to detect in vitro specific antibody p